Background. Carbon dioxide (CO 2 ) dose-dependently decreases minimum alveolar concentration (MAC) of anaesthetics in rats. CO 2 also dose-dependently decreases cerebrospinal fluid pH. N-methyl-D-aspartate (NMDA) channels exhibit pH sensitivity and are putative targets for inhaled anaesthetics. We hypothesized that CO 2 dose-dependently decreases rat NMDA channel current via an acidifying effect at concentrations relevant to CO 2 MAC.
Since at least the time of the Egyptian pharaohs, carbon dioxide (CO 2 ) has been used as an anaesthetic.
1 CO 2 is also a general anaesthetic, producing immobility to noxious stimuli at 1/3 atm in dogs 2 and at 1/2 atm in rats. 3 However, the mechanism for CO 2 general anaesthesia, as true for the mechanism for all inhaled anaesthetics, remains unknown. 4 The potency of conventional inhaled anaesthetics increases as a function of their lipid solubility. 5 However, the anaesthetic potency of CO 2 is much greater than would be predicted by its solubility in oil. 6 Unlike conventional inhaled anaesthetics, CO 2 decreases solution pH and decreasing cerebrospinal fluid (CSF) buffering capacity enhances CO 2 anaesthetic potency. 2 Thus, the narcotic effects of CO 2 may not be due to the CO 2 molecule itself.
Rather, CSF acidification alone could be the mechanism for CO 2 anaesthesia.
The N-methyl-D-aspartate (NMDA) receptor is a glutamatergic heterotetrameric cation channel with high calcium conductance composed of NR1 and NR2 subunits. 7 NMDA receptors are inhibited by acidosis 8 and NMDA-evoked neurone potentials are decreased by hypercapnia. 9 NMDA antagonism is thought to contribute to the immobilizing action of volatile anaesthetics 10 and the gaseous anaesthetics nitrous oxide and xenon. CO 2 should significantly and reversibly inhibit NMDA currents in vitro at concentrations that significantly decrease anaesthetic requirements for other inhaled agents in vivo. CO 2 should also inhibit NMDA currents as a function of extracellular pH; therefore, more alkaline solutions should obtund CO 2 antagonism. Finally, since PCO 2 produces a linear dose-dependent decrease in inhaled anaesthetic requirement in rats, PCO 2 should also produce a linear dose-dependent decrease in rat NMDA current.
Methods

Oocyte preparation and NMDA expression
Adult female South African clawed toed frogs (Xenopus laevis) were anesthetized in a 0.3% tricaine bath and unilaterally ovariectomized using a protocol approved by the Animal Use and Care Committee at the University of California, Davis. Eggs were defolliculated using 0.2% collagenase Type I (Worthington Biochemical, Lakewood, NJ, USA) and stored in modified Barth solution [88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 20 mM HEPES, 0.82 mM MgSO 4 , 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , 5 mM sodium pyruvate, gentamycin, penicillin, streptomycin, filtered, pH 7.4]. All salts were of analytical grade and obtained from Fisher Scientific (Pittsburgh, PA, USA).
Glutamate receptors were expressed using rat NMDA NR1 clones in a pCDNA3 vector and rat NMDA NR2A clones in a Bluescript vector, both of which were generously provided by the RA Harris laboratory (University of Texas, Austin, TX, USA). Genes were sequenced and compared with sequences in the National Center for Biotechnology Information database (BLAST) to confirm identities. Plasmids were linearized with the restriction enzymes ApaI and XhoI, respectively, and RNA was synthesized using T7 RNA from a commercially available kit (mMessage mMachine; Ambion; Austin, TX, USA). Transcripts were mixed in a 1:1 ratio, and 1 -10 ng of total RNA was injected into oocytes that were studied 1 -2 days later. Oocytes injected with similar volumes of water served as controls.
Study solutions
It is not possible to study NMDA current responses to solutions ver a wide range of CO 2 tensions at a fixed pH. The CO 2 -HCO 3 chemical equilibrium is described by the equation:
. Consequently, addition of NaOH to carbonated solutions to maintain constant pH reduces the PCO 2 , and subsequent addition of more CO 2 generates more NaHCO 3 . Carried to completion, isohydric solutions at PCO 2 tensions between 0% and 60% atm have different ionic activities, sodium concentrations, and may even exceed the solubility product for bicarbonate. Instead, a different study design was used. NMDA receptor responses to pH changes generated by direct addition of hydrogen ions were compared with pH changes generated by addition of CO 2 to isonatremic solutions that contained either 0 or 24 mM sodium bicarbonate. New solutions were made immediately before each experiment using !18.2 MV distilled water and analytical grade chemicals (Fischer Scientific, Hampton, NH, USA). All work was performed in Davis, CA, which is located 16 m above sea level. Electrophysiology measurements were made at ambient room temperature (238C). Only glass or polytetrafluoroethylene (PTFE) containers and tubing were used to avoid solution contamination by phthalates. 12 For PCO 2 test solutions, volumes of 99.999% CO 2 (Matheson Trigas, Newark, CA, USA) were added to sealed 100 ml gastight glass syringe pairs containing approximately 60 ml each of either barium frog Ringer's solution (BaFR: 115 mM NaCl, 2.5 mM KCl, 1.8 mM BaCl 2 , 10 mM HEPES, 0.1 mM EGTA, filtered, pH 7.4) or BaFR plus agonist (BaFREG: barium frog Ringer's solution plus 0.1 mM glutamate and 0.01 mM glycine; the single-letter amino acid codes for glutamic acid and glycine are E and G, respectively). Barium was substituted for calcium in perfusion solutions to avoid activating calcium-dependent chloride currents in Xenopus oocytes. 13 The concentrations of glycine and glutamate in the BaFREG solutions produce maximal NMDA current responses. Solutions were vigorously shaken for 5 min to equilibrate gas partial pressures. After expulsion of the gas headspace, PCO 2 in solutions were measured at 378C using a commercially available calibrated blood gas analyser (ABL5, Radiometer America, Westlake, OH) from samples collected via gastight syringe stopcocks. This was done to simultaneously measure pH and PCO 2 , which was otherwise not possible using headspace gas chromatography and a standard benchtop pH meter. Oxygen was added as needed to the syringe headspace to ensure an O 2 tension between 12 and 33 kPa (90 and 250 mm Hg). Further CO 2 or air headspace additions and equilibrations were used to achieve solutions pairs having the following PCO 2 (in % atm): 0, 10, 20, 30, 40, and 50. PCO 2 of each solution was measured again at the end of each experiment.
For PCO 2 plus bicarbonate test solutions, 24 mEq NaHCO 3 replaced an equimolar quantity of NaCl to make bicarbonate-BaFR (BaFR: 91 mM NaCl, 24 mM NaHCO 3 , 2.5 mM KCl, 1.8 mM BaCl 2 , 10 mM HEPES, 0.1 mM EGTA, filtered, pH 7.4) and bicarbonate-BaFREG (bicarbonate-BaFR plus 0.1 mM glutamate and 0.01 mM glycine). CO 2 was added to pairs of solutions and measured, as described above, to achieve the following PCO 2 (in % atm): 0, 10, 30, 50, 70, and 85. Solutions in syringes containing 85% atm CO 2 were first saturated with 100% O 2 before CO 2 additions, and the syringe gas cap was never exposed to room air. PCO 2 of each solution was measured again at the end of each experiment.
For pH test solutions, 1 M HCl was added to 13 pairs of BaFR and BaFREG solutions to generate a range of pH values between 5.3 and 7.4. The pH was measured at room temperature using a calibrated benchtop pH analyser (Accumet XL20, Fischer Scientific).
Study design
Oocytes were studied in a linear-flow perfusion chamber that had a 250 ml channel volume. All solutions were administered by a syringe pump (Pump 33, Harvard Apparatus, Holliston, MA, USA) at 1.5 ml min 21 using glass syringes and PTFE tubing during which a 280 mV membrane potential was maintained using a standard two-electrode voltage clamp technique (GeneClamp 500B, Axon Instruments, Union City, CA, USA). After a 5 min baseline measurement during perfusion with BaFR, the perfusate was switched to BaFREG for 30 s followed by a 5 min washout with BaFR. This was repeated three to four times to verify constancy of the control agonist response (,10% change in peak current).
The perfusate was then switched to the test solution in BaFR for a 5 min washin, followed by a 30 s exposure to the counterpart test solution in BaFREG. Test solution washout with BaFR ensued for 5 min followed by another 30 s exposure to BaFREG. Data were only used for analysis if NMDA current responses after washout differed by 10% from responses before washin of the test solution. Data were recorded by commercially available data acquisition software (Chart, version 5, AD Instruments, Colorado Springs, CO, USA).
Equipment calibration
The automated blood gas analyser was used to measure pH and PCO 2 of test solutions, since placing solutions in open air vessels required for benchtop pH meter analysis and headspace gas chromatography would have resulted in CO 2 loss and consequently an increase in measured pH. However, the blood gas analyser is not normally calibrated over the range of PCO 2 and pH values used in this study; moreover, gas partial pressures are measured at 378C which results in higher PCO 2 and lower pH values compared with measurements at ambient temperature (238C).
A CO 2 standard curve was required to correct blood gas analyser values. Known CO 2 standard concentrations spanning the range of experimental values were generated using Dalton's Law and a digital barometer (Fisherbrand Traceable, Fischer Scientific) and used to calibrate a gas chromatograph (Clarus 500, Perkin Elmer, Waltham, MA, USA). Chromatography was performed by gas injections directly on to a 1.8 m CTR-I concentrically packed column (Grace, Deerfield, IL, USA) with a 0.25 ml sample loop, 20 ml min 21 carrier gas flow rate, 1008C oven temperature, and 1208C detector temperature. This produced a 1.4 min CO 2 retention time and excellent separation from other air component peaks. Gas caps of different air and CO 2 mixtures were added to gastight glass syringes containing 50 ml BaFR. After vigorous shaking, syringes were placed in a temperature-calibrated rotating hybridization incubator (Model 400, SciGene, Sunnyvale, CA, USA) at 378C for 1 h. CO 2 concentration in the syringe headspace was then immediately measured by gas chromatography, and the BaFR PCO 2 was measured by the blood gas analyser. The resulting standard curve was linear only for 70% atm CO 2 . Consequently, the PCO 2 of test solutions containing 87% CO 2 was calculated by subtracting the PO 2 , which equalled 13.4 kPa (101 mm Hg) and fell within the instrument's automated calibration range, from the total barometric pressure.
The pH values for all samples were corrected to 378C. This was accomplished by constructing a standard curve for the benchtop pH meter using identical samples encompassing the entire study range measured at 258C and 378C. Because the pH of many test solutions were outside the automated calibration range, a standard curve was also constructed for the blood gas analyser and benchtop pH meter using samples measured at 378C.
Statistical analysis
Data were described by mean (SEM). The NMDA currentpH response curve was fit to the Hill equation from which the median effective pH ( pH 50 ) and Hill coefficient (n H ) were estimated using a pharmacology modelling programme (WinNonlin, Pharsight, Cary, NC, USA). Differences between the pH response curve and those for CO 2 or CO 2 þHCO 3 were analysed using t-tests with Dunn-Sidak corrections for multiple comparisons. Buffering capacity of BaFR and BaFRþHCO 3 solutions was analysed by linear regression (SPSS v.11) of pH and log 10 (CO 2 ) followed by a t-test of the slopes. Linear portions of the NMDA current-CO 2 response curves were analysed using linear regression, and the x-intercept was used to predict CO 2 concentration producing maximal NMDA channel inhibition. A P-value of ,0.05 was considered significant.
Results
Baseline NMDA currents in the presence of maximal agonist (BaFREG) ranged from 0.8-8.5 mA, indicating good receptor expression in oocytes. In contrast, sham-injected oocytes did not exhibit any current change when exposed to BaFREG solution. A sample NMDA current tracing is shown in Figure 1 . CO 2 and H þ both caused a concentration-dependent decrease in baseline NMDA current. After washout with BaFR solution, NMDA current responses to agonist were indistinguishable from baseline responses, indicating that effects of CO 2 and H þ on NMDA receptors are reversible (Fig. 1) .
As expected, pH decreased as a function of increasing CO 2 . The log-log regressions of H þ and CO 2 had an R 2 .98% for solutions with and without bicarbonate (Fig. 2) ; the slope of each line equals the buffering capacity of the corresponding solution. Differences between the buffering capacities for solutions with and without bicarbonate were modest, but statistically significant. The DpH/Dlog(%CO 2 ) was 21.39 (0.10) and 20.87 (0.02) for BaFR with and without bicarbonate, respectively.
The sigmoid pH -current response curve (Fig. 3 ) was described by a Hill equation having an absolute maximum NMDA current change (DI max ) equal to 298 (1)%, a current change without pH inhibition (DI 0 ) equal to 9 (3)%, a pH 50 equal to 6.52 (0.02), and an n H equal to 23 (1) where DI is the per cent change in NMDA current. Although control measurements were performed at pH¼7.4 at 238C, the pH after temperature correction to 378C was 7.24. If the Hill relationship is extrapolated back to pH¼7.4, DI increases approximately 4%. When plotted as a function of pH, the effects of CO 2 þHCO 3 on NMDA current were indistinguishable from the effects of pH alone (Fig. 3) . However, the addition of CO 2 alone to BaFR caused a left shift of the dose -response curve. Negative NMDA current modulation for the three highest values of the CO 2 curve-corresponding to the three lowest CO 2 concentrations in BaFR-was significantly less than for the comparable pH changes produced by HCl.
Equimolar NaCl replacement by NaHCO 3 reduced CO 2 potency as an NMDA antagonist (Fig. 4) . Addition of 10% CO 2 caused a much more precipitous decrease in NMDA current for BaFR solutions without NaHCO 3 , corresponding to a much greater decrease in solution pH. However, for larger partial pressures, absolute changes in NMDA inhibition for a given change in CO 2 were identical. Least squares slope estimates were 20.94 (0.06) and .0.97. Maximal NMDA inhibition was predicted for 56 (2)% atm CO 2 in BaFR. It is unknown whether the CO 2 -HCO 3 slope would remain constant at hyperbaric CO 2 concentrations; such an assumption suggests a lower bound for maximal NMDA inhibition at 114 (6)% atm CO 2 , equal to the x-intercept (Fig. 4) . The median inhibitory CO 2 concentration with the bicarbonate-containing solution was 63 (2)% atm, but was ,10% atm without bicarbonate addition.
Discussion
CO 2 causes reversible and concentration-dependent inhibition of NMDA receptor current. Moreover, the magnitude, pH dependence, and rectilinear NMDA current responses all support the relevancy of this receptor to the mechanism of action for CO 2 anaesthesia.
High PCO 2 produces general anaesthesia. The minimum alveolar concentration (MAC), equal to the end-tidal anaesthetic concentration that prevents movement in response to a maximal noxious stimulus in 50% of individuals, 14 is 32.6 kPa (245 mm Hg) in dogs 2 and 53.6 kPa (403 mm Hg) in rats. 3 Assuming an in vivo NMDA response similar to that for bicarbonate-buffered solutions, CO 2 at MAC should inhibit 20% of NMDA current in dogs and 40% in rats. Contemporary volatile anaesthetics at MAC inhibit NMDA current by 22-34%, 15 and spinal NMDA receptors contribute to the immobilizing action of these agents. 10 NMDA receptor inhibition likely also contributes to the mechanism of action of CO 2 anaesthesia. Since selective NMDA antagonists cannot by themselves cause complete anaesthesia in rats, 10 CO 2 must act on other anaesthetic-or pH-sensitive targets also.
Carbon dioxide exerts its effects on NMDA receptors principally through the acidification of extracellular fluid rather than by a direct interaction between receptors and 28 29 Hence, the pH change resulting from CO 2 addition to oocyte perfusates in vitro should reasonably approximate rat CSF pH changes expected from hypercapnia in vivo. 378C) by addition of 1 M HCl (pH curve), addition of CO 2 (CO 2 curve), or addition of CO 2 to a perfusate containing 24 mM NaHCO 3 (CO 2 þHCO 3 curve). Error bars represent SEM. *Points at which the CO 2 þHCO 3 curve differs significantly from the pH curve. At all other points, NMDA current inhibition is solely a function of pH. Hence, the primary mechanism of action for NMDA receptor antagonism is through an effect of CO 2 on pH, rather than a direct receptor interaction with the CO 2 molecule itself. the CO 2 molecule itself. Increased H þ concentration has previously been shown to act on the NR1 subunit surface loop encoded by exon 5 to inhibit NMDA receptor function. 16 When plotted as a function of pH, NMDA antagonism caused by HCl and CO 2 in bicarbonate-buffered solutions is identical. This suggests that H þ ions generated by carbonation likewise inhibit NMDA via an identical extracellular receptor effect on the exon 5 surface loop. In dogs, CO 2 potency is enhanced when CSF bicarbonateand hence buffering capacity-is decreased. Moreover, halothane MAC-sparing effects are more closely correlated with CSF pH than PCO 2 , with CSF pH approximately equal to 6.7 at 1 MAC of CO 2 in dogs. 2 The CSF pH in rats at 1 MAC of CO 2 is probably even more acidic, since the ED 50 of CO 2 is higher in rats than in dogs, resulting in an even greater degree of NMDA receptor negative modulation. Relevance of NMDA to CO 2 narcosis in vivo is thus supported by the pH-mediated NMDA antagonism of CO 2 in vitro.
Rat NMDA receptors exhibit rectilinear inhibition by CO 2 in bicarbonate-buffered solutions; that is to say, there is no threshold response observed. Similarly, CO 2 decreases volatile anaesthetic MAC rectilinearly in rats, 3 except that the slope of the NMDA current response is only 40% of the slope of the MAC response. In dogs, however, there is a CO 2 threshold response to decreasing halothane MAC. 2 Yet, the CSF pH threshold for MAC reduction in hypercapnic dogs still approximates the pH at which significant rat NMDA inhibition was observed. Therefore, different CO 2 MAC responses between dogs and rats may not arise from differences in NMDA or other receptor pH sensitivity, but rather from differences in CSF bicarbonate or CSF buffering capacity in the animals studied. Formulation of BaFR perfusates with a higher either bicarbonate concentration or buffering capacity than used in this study would require more CO 2 to reach a pH that inhibits NMDA current, thereby resulting in an apparent threshold response to CO 2 antagonism.
There remains a small, but significant, CO 2 effect for which extracellular pH ( pH e ) does not account, as evidenced by differential inhibition from CO 2 -and HCl-containing solutions at equivalent pH. Xenopus oocytes lack an endogenous bicarbonate current; 17 thus, the 24 mM bicarbonate vs chloride ion composition difference between perfusates is alone insufficient to explain this observation.
For a given pH e , CO 2 tension is higher in BaFR solutions that contain bicarbonate than those that do not. Yet unlike hydrogen ions, CO 2 can rapidly diffuse across cell membranes 18 and decrease intracellular pH ( pH i ). Hence, under extracellular isohydric conditions, pH i is lower in BaFR solutions that contain bicarbonate than those that do not. Deviation of the CO 2 dose -response curve from that of pH alone suggests that either CO 2 or the attending acidosis can interact with a second site that is not easily accessible to H þ -perhaps a transmembrane or intracellular site-that could positively modulate NMDA receptor function 19 and thus oppose channel inhibition by extracellular protons. In contrast, the CO 2 þHCO 3 response does not deviate from that of pH alone. Since PCO 2 is higher in BaFRþHCO 3 solutions than in isohydric BaFR counterparts, pH i must also be lower in BaFRþHCO 3 solutions than in BaFR solutions for a given pH e . Thus, marked intracellular acidosis in BaFRþHCO 3 solutions with high PCO 2 may alter the structural conformation of transmembrane or intracellular portions of NMDA subunits, consequently nullifying the binding or efficacy of CO 2 at this second site of action.
The NMDA current pH 50 in this study was 6.52. However, in rat cerebellar granule cells, NMDA currents are 50% of maximum at pH¼7.3. 8 This discrepancy could result from differences between the NMDA subunits expressed or between the cellular expression models. Additionally, neuronal NMDA measurements were reported for room temperature. If corrected to 378C using the BaFR standard curve from this study, the NMDA pH 50 in cerebellum neurones is approximately 7.1. Correcting pH and gas partial pressures to normal body temperature allows comparison of in vivo and in vitro physiologic responses for a comparable per cent of ionized imidazole moieties on the receptor protein. 20 Moreover, if identical systems at different temperatures are compared at the same PCO 2 , then the cooler system will have a lower CO 2 activity and a higher solubility coefficient and aqueous CO 2 content. Hence, CO 2 partial pressure would appear a more potent NMDA inhibitor at lower temperatures because there is more dissolved CO 2 . This is analogous to ED 50 -temperature relationships observed with alcohols and inhaled anaesthetics, for which potency is also a function of aqueous-and not gas phase-concentration. 21 22 Nonetheless, the open probability and conductance through open NMDA receptors-and also agonist and antagonist association time constants with activated receptors-decrease as temperature decreases, 23 24 and hence the temperature used for measurement may still cloud to some degree in vivo and in vitro comparisons.
NMDA inhibition by CO 2 implies that hypoventilation might exhibit the pharmacologic effects common to other NMDA antagonists, such as amnesia and analgesia. In evidence, the long-term potentiation, an NMDA-mediated enhancement of synaptic connections important for learning and memory, is inhibited in rat hippocampus slices by 20% CO 2 . 25 Remarkably, humans breathing only 6.5% CO 2 perform markedly slower on reasoning tests and have a tendency, albeit not statistically significant, to forget new facts. 26 Furthermore, rats that inhale 70/30% CO 2 /O 2 for 30 s exhibit antinociception to hot plate, tail flick, and tail pinch tests for at least 1 h after exposure. 27 If these phenomena are due in part to NMDA antagonism, then the present study would suggest that even small current decreases caused by CO 2 could have important and longlasting effects, perhaps most importantly during and after anaesthesia and surgery. Thus, the central nervous system effects of hypoventilation may be as widespread as the NMDA receptor itself.
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